Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study May 10, 2026 Rebecca Shoemaker New research indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs widely used for managing type 2 diabetes and obesity, may also offer significant benefits for mental well-being.…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health, Reducing Psychiatric Hospitalizations and Work Absences April 28, 2026 Rebecca Shoemaker New, large-scale research involving nearly 100,000 individuals has unveiled a significant correlation between the use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic, Wegovy, and Rybelsus),…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study April 13, 2026 Rebecca Shoemaker New research spearheaded by an international consortium of scientists is shedding light on a potential, and perhaps unexpected, benefit of GLP-1 receptor agonists, a class of medications widely recognized for…
Psychology & Intimacy GLP-1 Medications Show Remarkable Links to Improved Mental Health Outcomes, New Large-Scale Study Reveals April 6, 2026 Rebecca Shoemaker Groundbreaking research conducted by an international consortium of scientists from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia has unveiled a significant association between…
